Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 
Online Report Subscribers, Click Here

Pricing and Ordering Information
ClearState

Japan Disease Incidence & Prevalence Report
Report #CS305JP -
June 2013


Japan Disease Incidence and Prevalence: A rapidly aging population is driving the increasing incidence of chronic diseases

Japan has a population of almost 128 million people and has one of the best healthcare systems in the Asia-Pacific region. Unlike China and India, Japan has universal healthcare coverage that allows citizens to have easy and affordable access to medical treatment. Healthcare spending in Japan accounts for a remarkable 9.5% of total GDP, and it is expected to be maintained at the same rate for the next few years.

The Japanese have one of the longest life expectancies in Asia and, together with the low birth rate, this statistic accounts for the rapidly ageing population. Due to Japan's large proportion of elderly people, chronic diseases are the main burden on the healthcare system with hypertension and osteoarthritis being the most prevalent diseases in Japan, along with old age-related diseases such as cataracts which are also increasingly prevalent. Thus, ophthalmology and orthopedic procedure volumes in Japan are very high and are expected to grow quickly in the next few years.

It is estimated that 1 in 4 Japanese adults suffer from cardiovascular diseases, while metabolic diseases affect as many as 1 in 5 people. There were 700,000 cases of cancer in Japan in 2012, with colorectal and stomach cancers contributing the bulk of cases with stomach cancer being among the top ten causes of death in Japan. In terms of infectious disease, most of those that affect developing nations have been eradicated. The main infectious diseases affecting Japan are tuberculosis and enterohaemorrhagic E. coli both of which, however, are difficult to eradicate due to evolving strains of drug resistant bacteria.

Ordering Information

Title

Report# Publication
Date
List Price

Japan Disease Incidence & Prevalence Report

CS305JP

June 2013

$5,950

Order Online:
Single User only (Please call for corporate subscription pricing)
    PDF Only

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

METHODOLOGY STATEMENT

INTRODUCTION

 

1. JAPAN HEALTHCARE OVERVIEW

1.1 Macroeconomic Overview

1.2 Social and Demographic Factors

1.3 Hospital Services

1.4 Medical Devices

 

Exhibit 1-1:      Key Economic and Health Statistics, 2012

Exhibit 1-2:      Top 10 Causes of Death in Japan

 

2. BLOOD DISORDERS

2.1 Anaemia

2.2 Haemophilia

 

Exhibit 2-1:      Japan, Prevalence of Blood Disorders

 

3. CANCER

 

3.1 Bladder Cancer

3.2 Breast Cancer

3.3 Cervical/Uterine Cancer

3.4 Colon/Rectal Cancer

3.5 Leukaemia

3.6 Liver Cancer

3.7 Lung Cancer

3.8 Lymphoma

3.9 Melanoma

3.10 Oesophageal Cancer

3.11 Oral Cancer

3.12 Ovarian Cancer

3.13 Pancreatic Cancer

3.14 Prostate Cancer

3.15 Stomach Cancer

 

Exhibit 3-1:      Japan, Incidence of Cancer

 

4. CARDIOVASCULAR DISORDERS

4.1 Cardiac Arrhythmia

4.2 Dyslipidemia

4.3 Heart Failure

4.4 Heart Valve Disorders

4.5 Hypertension

4.6 Vascular Disorders

 

Exhibit 4-1:      Japan, Prevalence of Cardiovascular Disorders

 

5. METABOLIC DISORDERS

5.1 Cholelithiasis and Cholecystitis

5.2 Chronic Kidney Disease / End-Stage Renal Disease

5.3 Diabetes

5.4 Urolithiasis

 

Exhibit 5-1:      Japan, Prevalence of Metabolic Disorders

 

6. MUSCULOSKELETAL DISORDERS

6.1 Arthritis

6.2 Carpal Tunnel Syndrome

6.3 Intervertebral Disc Disorder

6.4 Osteoporosis

 

Exhibit 6-1;      Japan, Prevalence of Musculoskeletal Disorders

 

7. NEUROLOGIC AND PSYCHIATRIC DISORDERS

7.1 Alzheimer’s Disease

7.2 Bipolar Disorder

7.3 Cerebrovascular Disease

7.4 Depression

7.5 Epilepsy

7.6 Hydrocephalus

7.7 Multiple Sclerosis

7.8 Parkinson’s Disease

7.9 Schizophrenia

7.10 Amyotrophic Lateral Sclerosis

 

Exhibit 7-1:      Japan, Prevalence of Neurologic and Psychiatric Disorders

 

8. OPHTHALMIC DISORDERS

8.1 Cataracts

8.2 Glaucoma

 

Exhibit 8-1:      Japan, Prevalence of Ophthalmic Disorders

 

9. REPRODUCTIVE AND GENITOURINARY DISORDERS

9.1 Benign Prostatic Hyperplasia

9.2 Endometriosis

9.3 Erectile Dysfunction

9.4 Infertility

9.5 Urinary Incontinence

 

Exhibit 9-1:      Japan, Prevalence of Reproductive and Genitourinary Disorders

 

10. RESPIRATORY DISORDERS

10.1 Asthma

10.2 Chronic Obstructive Pulmonary Disease

 

Exhibit 10-1:    Japan, Prevalence of Respiratory Disorders

 

11. WOUNDS

11.1 Diabetic Ulcer

11.2 Surgical Wounds

11.3 Traumatic Wounds

 

Exhibit 11-1:    Japan, Incidence of Wounds

 

12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS

12.1 Measles

12.2 Human Immunodeficiency Virus / Acquired Immune Deficiency Syndrome

12.3 Tuberculosis

12.4 Viral Hepatitis

12.5 Enterohaemorrhagic Escherichia coli

12.6 Syphilis

 

Exhibit 12-1:    Japan, Incidence of Conditions Caused by Infectious Organisms

 

APPENDIX: REFERENCES

Clearstate is a market intelligence firm offering customized strategic advisory and primary research solutions specifically addressing the Healthcare and Life Sciences domains within the Asia Pacific region. www.clearstate.com

To order reports or obtain information about special pre-publication offers from within the U.S., contact custcare@informa.com. You can also call 1.908.748.1221 (or toll-free within the U.S. at 1.800.332.2181) or fax 1.908.748.1222.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home